10 Best Pharmaceutical Stocks to Buy in 2022
In this article, we discuss the 10 best pharmaceutical stocks to buy in 2022.
Collegium Pharmaceutical Inc (COLL)
Get Email AlertsSector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 9,500,000 | $89,474 | -46% | 1.79% | |
| 2. | Rubric Capital Management David Rosen | 3,000,000 | $61,080 | +16% | 2.2% |
| 3. | 31,945,000 | $30,087 | 0.7% | ||
| 4. | Renaissance Technologies Jim Simons | 1,270,118 | $25,860 | +2% | 0.03% |
| 5. | Camber Capital Management Stephen Dubois | 1,050,000 | $21,378 | 0.77% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.18 | 10,000 | Officer | 110,227 | 2017-05-12 | Filing | |
| $10.59 | 2,375 | Director | 2,375 | 2016-08-12 | Filing | |
| $12.00 | 3,930 | Large Shareholder | 65,270 | 2015-05-12 | Filing | |
| $12.00 | 196,070 | Large Shareholder | 3,256,572 | 2015-05-12 | Filing | |
| $12.00 | 150,000 | Large Shareholder, Director | 1,887,332 | 2015-05-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $19.04 | 11,011 | Officer, Director | 324,847 | 2022-03-01 | Filing | |
| $18.37 | 65,083 | Officer, Director | 335,858 | 2022-03-01 | Filing | |
| $21.61 | 10,559 | Officer | 121,226 | 2022-02-18 | Filing | |
| $18.33 | 5,693 | Officer | 76,970 | 2021-12-15 | Filing | |
| $22.81 | 5,861 | Officer, Director | 267,774 | 2021-06-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 28,715 | $584,637 | 0% | |
| 2. | 12,199 | $248,372 | 0% | |
| 3. | 5,717,305 | $116,403 | 0% | |
| 4. | 2,629,593 | $53,539 | 0.83% | |
| 5. | 2,356,782 | $47,983 | 0.02% |
News See All
10 Cheap Pharmaceutical Stocks For 2022
The pharma industry is in the midst of a fundamental transformation as disruptive technologies like artificial intelligence, machine learning, and natural language processing become dominant trends in...
10 Growth Stocks Under $20 in Billionaire Ken Fisher’s Portfolio
In this article, we discuss the 10 growth stocks under $20 in billionaire Ken Fisher's portfolio.
10 Best Biotech Stocks to Buy According to Joseph Edelman’s Perceptive Advisors
In this article, we will discuss the 10 best biotech stocks to buy according to Joseph Edelman’s Perceptive Advisors.
5 Best Pharmaceutical Stocks to Buy According to Billionaire Joseph Edelman
In this article, we discuss the 5 best pharmaceutical stocks to buy according to billionaire Joseph Edelman.
Is COLL A Good Stock To Buy Now?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Collegium Pharmaceutical Inc (COLL): Hedge Funds Taking Some Chips Off The Table
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Did Hedge Funds Make The Right Call On Collegium Pharmaceutical Inc (COLL) ?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Hedge Funds Keep Buying Collegium Pharmaceutical Inc (COLL)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
These Hedge Funds Cashed Out Of Collegium Pharmaceutical Inc (COLL) Too Early
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Billionaire Hedge Funds
